Bayer, Curadev Enter ‘STING’ Pact Exploring Inflammatory Disease

Duo Using Curadev’s Stimulator Of Interferon Genes Antagonist Platform

 
• By Sten Stovall
  
Inflammation_Stethoscope
The STING agonist program aims to kick-start innate immune responses in tumors • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip